-
YIRU WANG
Partner·Shanghai
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
MR. WANG SPECIALIZES IN PRIVATE EQUITY, CROSS‐ BORDER RESTRUCTURING, MERGER AND ACQUISITION.
Education
New York University, School of Law, LLM
East China University of Political Science and Law, LLB
Professional Qualification
Admitted to practice in the PRC
Admitted to practice in New York
Professional Background
Mr. Wang joined Fangda Partners in 2015. Prior to joining Fangda Partners, he worked with a leading Chinese domestic law firm.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Represented Ant Financial in its investment in Hellobike, the operator of the largest bike-sharing platform in China, and relevant cross-border restructuring of Hellobike
- Represented Ant Financial in its investment in a strategic joint venture with Hellobike and CATL
- Represented Warburg Pincus in the cross-border restructuring and subsequent listing on NEEQ of Kidswant, a leading maternity-infant-children specialty retailer
- Represented Warburg Pincus in the cross-border restructuring and subsequent IPO of Liepin, the largest mid-senior level professional & talent online platform in China
- Represented Goldman Sachs in the cross-border restructuring and subsequent IPO of Ascletis Pharma, a leading biotechnology company
- Represented Alibaba in its investment in AISpeech, a leading speech technology platform
- Represented Alibaba and YF Capital in its investment in Qiniu Cloud, a leading enterprise cloud service supplier
- Represented YF Capital in its investment in Montage Tech, a leading provider of analog and mixed-signal semiconductor solutions
- Represented YF Capital in its investment in Leyan Tech, a leading artificial intelligence customer service provider
- Represented Hillhouse in its investment in Gaodun, a leading online professional education service provider
- Represented ANE Logstics, a leading trucking and logistics services provider, in its share structure restructuring and equity financing
- Represented Pipilu, a leading children entertainment content and products provider, in its cross-border restructuring and equity financing
- Represented MitrAssist, an Isreali medical device manufacturer, in its share structure restructuring and equity financing
- Represented CstonePharma, a biopharma company focused on developing innovative immuno-oncology and molecularly targeted drugs, in its pre-IPO restructuring
- Represented WukongZhaoFang, Panda ABC, Eddingpharm in their equity financings
- Represented City Development Limited in its RMB 4.4 billion acquisition of equity in Chongqing Sincere
- Represented Eddingpharm in its US$375 million acquisition of certain onshore business of Lilly
- Represented Fujian Automobile Group Limited on the RMB 690 million acquisition of 35% equity in Fujian Benz Automotive Co., Ltd. (a Sino-foreign joint venture) by BAIC Motor Corporation Limited (01958.HK)
- Represented Morgan Stanley on the RMB800 million acquisition of 11% equity in Hangzhou Trust by Greenland Holdings Group Corporation Limited (600606)
- Represented Warburg Pincus in its acquisition of equity in a company engaged in education business
- Represented Vastec Medical Limited on the US$60 million takeover by Shinva Medical Instrument Co., Ltd. (600587)
- Represented Suzhou Anjie Technology Co., Ltd. (002635) on its US$145 million takeover of Supernova Holdings (Singapore) Pte. Ltd.
